The biobank is a type of biorepository which stores the biological samples, usual humans for use in future research.These biobanks play a vital role in drug discovery and disease research. Biobanks give access to samples which are collected by doctors for their research studies. These storages may range from a refrigerator to warehouse, hospitals, universities and pharmaceutical companies.
The Middle East & Africa Biobanks Market Segments Size & Growth:
The Middle East & Africa BiobanksMarket is accounted for $38billion in 2017 and expected to grow at a CAGR of 11% to reach $62 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth due to rapid growth in population increase in chronic diseases, and advancements in biobanking techniques. However, surveillance issues and storage problems hinder the growth of theMiddle East & Africa biobanks market.
The Middle East & Africa Biobanks Market Segments Share:
The Middle East & Africa BiobanksMarket is categorised into by-product which consists of
By Geography, South Africa is dominating the biobanks market, and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalised medicine and rise in cancer cases. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
The Middle East & Africa Biobanks Market Segments Trends:
The Middle East & Africa Biobanks Research Report:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.